Lipitor Lawsuits Consolidated in South Carolina, Announces Lawyer Kenneth Suggs, of Janet, Jenner & Suggs, LLC

  Lipitor Lawsuits Consolidated in South Carolina, Announces Lawyer Kenneth
                     Suggs, of Janet, Jenner & Suggs, LLC

PR Newswire

COLUMBIA, S.C., Feb. 20, 2014

COLUMBIA, S.C., Feb. 20, 2014 /PRNewswire/ --Lipitor lawsuits filed in
federal courts on behalf of people who allegedly developed type 2 diabetes
after taking Pfizer's cholesterol-lowering statin, also called atorvastatin,
have been consolidated in the District of South Carolina according to a court
order filed Feb. 18, (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502
(JPML)), announced Janet, Jenner & Suggs attorney Kenneth Suggs, who is
representing plaintiffs.

(Photo: http://photos.prnewswire.com/prnh/20140220/DA68529)

"The Hon. Judge Richard M. Gergel, who has been appointed to oversee the new
Multidistrict Litigation (MDL) has been involved in these cases for more than
a year and was the obvious and best choice," said Suggs, a principal in the
firm who also heads the firm's South Carolina office. "Judge Gergel is already
presiding over 27 of these cases in South Carolina. This experience will be
invaluable going forward," Suggs added.

Janet, Jenner & Suggs represents victims of dangerous drugs and medical
devices nationwide. The firm is offering free consultations to anyone who has
been diagnosed with type 2 diabetes after they began taking Lipitor, Suggs
said.

Suggs recently was named Columbia, SC, 2014 "Lawyer of the Year" in the area
of Personal Injury Litigation – Plaintiffs by Best Lawyers®. He also is listed
among the "100 Most Influential" trial attorneys in the nation by the National
Trial LawyersAssociation publication, The Trial Lawyer. This marked the
fourth time Mr. Suggs received this distinction.

Hundreds of lawsuits are pending against Pfizer alleging the company "failed
to warn physicians and consumers adequately of the risk of developing type 2
diabetes from taking Lipitor; knew or should have known that the risks of
Lipitor included developing diabetes; and negligently, recklessly, and/or
carelessly marketed Lipitor without adequate instructions or warnings."

By consolidating the lawsuits, the court will be able to conserve resources,
avoid duplication of discovery, and prevent inconsistent pretrial rulings.
"The creation of an MDL benefits plaintiffs considerably because it allows for
more efficient handling of the cases," said Suggs' partner, Robert K. Jenner,
who heads the law firm's Mass Tort Division.

In 2012 the FDA issued warnings about side effects of Lipitor, including the
risk of diabetes, after a large-scale study showed the danger of developing
type 2 diabetes from Lipitor was particularly high in middle-aged and older
women.

People who developed type 2 diabetes after they began taking Lipitor may be
entitled to compensation for medical bills, lost income, and pain and
suffering. To find out more about filing a Lipitor lawsuit, go to
MyAdvocates.com, or call 1-877-My-Advocates (692-3862).

Janet, Jenner & Suggs is a national firm noted for its expertise in dangerous
drugs and medical devices, birth injury and cerebral palsy cases, and
environmental litigation. The firm has offices in Maryland, South Carolina,
Massachusetts, New York, Washington, D.C., Pennsylvania, North Carolina,
Minnesota, and West Virginia. Its headquarters office is in Baltimore.

Contact:
Teresa Kelly
1-512-328-4276
teresapkelly@msn.com

SOURCE Janet, Jenner & Suggs, LLC

Website: http://myadvocates.com/
 
Press spacebar to pause and continue. Press esc to stop.